# Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer

> **NCT00845611** · PHASE1 · COMPLETED · sponsor: **Kinki University** · enrollment: 9 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **BIOLOGICAL:** peptide vaccine

## Key facts

- **NCT ID:** NCT00845611
- **Lead sponsor:** Kinki University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2012-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845611, "Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00845611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*